Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VALIC Company I Small Cap Index Fund (VCSLX)

19.86
Net Asset Value
+0.81%
1 Day
-9.02%
Year-to-Date
Overall Morningstar Rating
Small blend
Style or Category
No Load
Sales Expenses
0.40%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide growth of capital. The fund invests, under normal circumstances, at least 80% of net assets in stocks that are in the Russell 2000  Index. It is managed to seek to track the performance of the index, which measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

Performance

1 month-4.93% 3 years+14.01%
3 months-6.94% 5 years+14.88%
1 year+0.98% Since inception+9.23%
Data through --

Peer Comparisonvs. Small blend

 VCSLXCategory
Performance 5-yr return+14.88%+15.95%
Expense ratio0.40%1.25%
Risk 5 year sharpe ratio0.930.90
Net assets$1.1B$885.8M
Average market cap$1.6B$2.8B
Average P/E20.520.6
Portfolio turnover14%14%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureTimothy Campion / 3 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock95.58%
Cash3.32%
International stock1.05%
Fixed income0.05%
Other0.01%
Top 5 Sectors
Portfolio weighting
Financial service 19.92%
Industrial materials 13.46%
Healthcare 11.18%
Consumer goods 9.19%
Business service 8.90%
Top 10 Holdings
Portfolio weighting
-- 3.69%
TMH TeamHealth Holdings Inc0.23%
CPHD Cepheid0.22%
MANH Manhattan Associates Inc0.22%
MMS Maximus Inc0.21%
HLS HealthSouth Corp0.21%
TYL Tyler Technologies Inc0.21%
WST West Pharmaceutical Services Inc0.21%
ISBC Investors Bancorp Inc0.21%
NBIX Neurocrine Biosciences Inc0.20%

Partner Offers